In a 4-week experiment employing Mdr2 (−/−) mouse model of primary sclerosing cholangitis (PSC), it was found that Nor-UDCA can improve the sclerosing cholangitis in mice (13). This evidence concerns the gene ABCB4 and sclerosing cholangitis.